ArticleJournal of applied clinical medical physics2026
Radiation dose optimization in coronary CT angiography clinical application of absolute phase gating in patients with atrial fibrillation.
Article in Journal of applied clinical medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAtrial fibrillation (AF) poses significant challenges for coronary CT angiography (CCTA) due to R-R interval variability, often necessitating high radiation dose protocols. Absolute phase gating, which uses fixed millisecond delays rather than percentage-based cardiac cycle timing, may optimize image quality while reducing radiation exposure. PURPOSE: To evaluate whether absolute phase gating reduces radiation dose while maintaining diagnostic accuracy and image quality compared to conventional relative phase gating in patients with AF undergoing CCTA.
methodsThis retrospective matched cohort study included 280 consecutive patients with AF (140 per group) who underwent CCTA between January 2021 and December 2023. Patients were matched by heart rate, BMI, and calcium score. The absolute phase gating group used fixed 300-millisecond post-R-wave triggering; the relative phase gating group used conventional 75% R-R interval triggering. Primary endpoints were diagnostic accuracy (sensitivity, specificity) for ≥50% stenosis and assessable segment ratio. Secondary endpoints included radiation dose parameters and image quality scores. Invasive coronary angiography served as reference standard in 118 patients (42.14%).
resultsRadiation dose was 64.28% lower with absolute phase gating (median DLP: 187.50 vs. 524.80 mGy·cm, p < 0.001; median effective dose: 2.63 vs. 7.35 mSv, p < 0.001). Diagnostic accuracy remained comparable (sensitivity: 96.61% vs. 94.74%, p = 0.524; specificity: 89.47% vs. 86.67%, p = 0.612). Assessable segment ratio significantly improved (99.05% vs. 95.71%, p < 0.001). Mean image quality scores were higher with absolute gating (3.21 ± 0.58 vs. 2.84 ± 0.71, p < 0.001).
conclusionsIn patients with AF undergoing CCTA, absolute phase gating can potentially reduce radiation dose while maintaining or improving diagnostic performance relative to the conventional relative phase gating protocol used at our institution. Because the magnitude of any dose reduction depends in part on the acquisition window and dose-modulation settings of the compared protocols, the benefit should be interpreted in the context of the specific comparator. These findings are consistent with the Image Wisely initiative for responsible patient radiation dose management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.